MedtechWOMEN Announces Deborah Kilpatrick as Winner of the 2024 Ferolyn Powell Award
MedtechWOMEN has named Deborah Kilpatrick, PhD, Executive Chair and former CEO of Evidation Health, as the recipient of the 2024 Ferolyn Powell Award. This prestigious honor recognizes leaders in medical technology who embody excellence, innovation, and mentorship. Kilpatrick, a co-founder of MedtechWOMEN, accepted the award at the annual MedtechVISION conference in Menlo Park, California.
Kilpatrick's career spans leadership roles at Guidant and Evidation Health. She currently advises medtech and digital health startups, and serves as a director at Sleep Number (NASDAQ: SNBR), NextGen Jane, and Sutter Health. The award highlights her commitment to advancing diversity and innovation in the medtech industry, aligning with the values championed by Ferolyn Powell.
MedtechWOMEN ha nominato Deborah Kilpatrick, PhD, Presidente Esecutivo e ex CEO di Evidation Health, come destinataria del 2024 Ferolyn Powell Award. Questo prestigioso riconoscimento premia i leader nel settore della tecnologia medica che incarnano l'eccellenza, l'innovazione e la mentorship. Kilpatrick, co-fondatrice di MedtechWOMEN, ha accettato il premio durante l'annuale MedtechVISION conference a Menlo Park, in California.
La carriera di Kilpatrick include ruoli di leadership presso Guidant ed Evidation Health. Attualmente, consiglia startup nel settore medtech e della salute digitale, ed è direttrice presso Sleep Number (NASDAQ: SNBR), NextGen Jane e Sutter Health. Il premio sottolinea il suo impegno per promuovere la diversità e l'innovazione nell'industria medtech, in linea con i valori sostenuti da Ferolyn Powell.
MedtechWOMEN ha nombrado a Deborah Kilpatrick, PhD, Presidenta Ejecutiva y ex CEO de Evidation Health, como la receptora del 2024 Ferolyn Powell Award. Este prestigioso honor reconoce a los líderes en tecnología médica que encarnan la excelencia, la innovación y la mentoría. Kilpatrick, cofundadora de MedtechWOMEN, aceptó el premio en la conferencia anual MedtechVISION en Menlo Park, California.
La carrera de Kilpatrick abarca roles de liderazgo en Guidant y Evidation Health. Actualmente, asesora a startups de medtech y salud digital, y es directora de Sleep Number (NASDAQ: SNBR), NextGen Jane y Sutter Health. El premio resalta su compromiso con la promoción de la diversidad y la innovación en la industria medtech, alineándose con los valores defendidos por Ferolyn Powell.
MedtechWOMEN은 Deborah Kilpatrick, PhD를 2024 Ferolyn Powell Award의 수상자로 선정했습니다. 이 권위 있는 상은 의료 기술 분야의 리더들이 우수성, 혁신 및 멘토십을 구현함을 인정합니다. MedtechWOMEN의 공동 창립자인 Kilpatrick는 캘리포니아 멘로파크에서 열린 연례 MedtechVISION conference에서 상을 수상했습니다.
Kilpatrick의 경력은 Guidant 및 Evidation Health에서의 리더십 역할을 포함합니다. 현재 그녀는 medtech 및 디지털 헬스 스타트업을 자문하며, Sleep Number (NASDAQ: SNBR), NextGen Jane, Sutter Health에서 이사로 활동하고 있습니다. 이 상은 그녀가 medtech 산업에서 다양성과 혁신을 발전시키기 위한 헌신을 강조하며, Ferolyn Powell이 지지하는 가치를 반영합니다.
MedtechWOMEN a nommé Deborah Kilpatrick, PhD, Présidente Exécutive et ancienne PDG d'Evidation Health, comme la lauréate du 2024 Ferolyn Powell Award. Cet honneur prestigieux reconnaît les leaders en technologie médicale qui incarnent l'excellence, l'innovation et le mentorat. Kilpatrick, cofondatrice de MedtechWOMEN, a accepté le prix lors de la conférence annuelle MedtechVISION à Menlo Park, Californie.
La carrière de Kilpatrick comprend des rôles de leadership chez Guidant et Evidation Health. Actuellement, elle conseille des startups en medtech et santé numérique, et elle est administratrice chez Sleep Number (NASDAQ: SNBR), NextGen Jane et Sutter Health. Le prix met en évidence son engagement à promouvoir la diversité et l'innovation dans l'industrie medtech, en accord avec les valeurs défendues par Ferolyn Powell.
MedtechWOMEN hat Deborah Kilpatrick, PhD, Vorsitzende und ehemalige CEO von Evidation Health, als Empfängerin des 2024 Ferolyn Powell Award ausgezeichnet. Diese prestigeträchtige Auszeichnung erkennt Führungspersönlichkeiten in der Medizintechnologie an, die Exzellenz, Innovation und Mentorship verkörpern. Kilpatrick, Mitbegründerin von MedtechWOMEN, nahm den Preis auf der jährlichen MedtechVISION conference in Menlo Park, Kalifornien, entgegen.
Kilpatricks Karriere umfasst Führungspositionen bei Guidant und Evidation Health. Derzeit berät sie Medtech- und digitale Gesundheitsstartups und ist Direktorin bei Sleep Number (NASDAQ: SNBR), NextGen Jane und Sutter Health. Die Auszeichnung hebt ihr Engagement für die Förderung von Vielfalt und Innovation in der Medizintechnologie hervor und stimmt mit den von Ferolyn Powell geförderten Werten überein.
- None.
- None.
The award, named in honor of medtech pioneer Ferolyn Powell, celebrates leaders in the medical technology field who exemplify excellence, innovation, and a commitment to mentoring the next generation of leaders—values Ferolyn championed throughout her career.
Kilpatrick accepted the award today during the annual MedtechVISION conference taking place at the Rosewood Sand Hill in
Amy Belt Raimundo, co-founder of MedtechWOMEN, reflected on the significance of this honor for Kilpatrick. “As her co-founder, I know firsthand how tirelessly Deb works to support and elevate women in our industry. This was the purpose of MedtechWOMEN. And Deb’s contributions go way beyond that. Just as Ferolyn was, Deb is a champion of excellence, of developing others, and advancing the field—all in the service of improving outcomes for patients. She holds the deep belief that elevating the diversity of talent and voices will make our solutions stronger, and she lives that belief every day.”
"I am deeply honored to receive this year’s Ferolyn Powell Award. Ferolyn was both a mentor and an advocate for lifting up others as she advanced the medtech field herself, and she knew how to leverage the power of diversity to drive innovation,” said Kilpatrick. “To be recognized in her name is incredibly meaningful to me, and I am grateful to MedtechWOMEN for this honor and for continuing to foster the values that Ferolyn championed."
Kilpatrick began her medtech career at Guidant Corporation, where she held multiple leadership roles, including Research Fellow, Director of R&D, and Director of New Ventures in the Vascular Intervention Division, before its acquisition by Abbott and Boston Scientific. In addition to her leadership role at Evidation Health, Kilpatrick advises several medtech and digital health startups and serves as a director at Sleep Number (NASDAQ: SNBR), women’s health company NextGen Jane, and Sutter Health.
About MedtechWOMEN
MedtechWOMEN is an organization founded by women leaders in the medical technology industry, dedicated to highlighting the contributions of women and advancing the conversation around key issues in medtech. The group’s mission is to foster and promote the role of women in the field and to provide a platform for collaboration, mentorship, and the sharing of best practices to drive the industry forward.
For more information, visit www.medtechwomen.org.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240910898915/en/
Media Contact:
Nicole Osmer
Health+Commerce
nicole@healthandcommerce.com
Source: MedtechWOMEN
FAQ
Who won the 2024 Ferolyn Powell Award from MedtechWOMEN?
What is Deborah Kilpatrick's role at Sleep Number (SNBR)?
Where was the 2024 MedtechVISION conference held?
What are some of Deborah Kilpatrick's previous roles in the medtech industry?
What other companies is Deborah Kilpatrick involved with besides Sleep Number (SNBR)?
